Luminostics has been awarded a contract by the National Institutes of Health (in collaboration with the Biomedical Advanced Research and Development Authority) under the Rapid Acceleration of Diagnostics Tech (RADx Tech) fast track program, which supports the development and commercialization of innovative technologies to significantly increase the U.S. testing capacity for SARS-CoV-2, the virus that causes COVID-19. Read the NIH press release for additional information.
More Recent News
Clip Health® Previewed its New Over the Counter COVID-19 Test at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo
Clip Health was one of over 700 exhibitors at this year’s American Association of Clinical Chemistry (AACC) Annual Scientific Meeting held in Chicago at the McCormick Place Convention Center on July 24 – 28, demonstrating the fastest rapid antigen test on the market. Their newest COVID-19 test was submitted to the U.S. Food and Drug…
With COVID testing on the wane, small diagnostics companies shift focus
Small companies that won big testing contracts earlier in the pandemic are now seeing COVID-19 testing shift to the home. Next to big-name brands like Abbott Laboratories and Becton Dickinson, a swath of lesser-known companies are selling COVID-19 tests to schools, hospitals and corporations. Buoyed by the pandemic, these small firms and startups have seen…